Monoclonal antibody 266

Drug Profile

Monoclonal antibody 266

Alternative Names: Anti-Abeta Antibody m266 Fab; Anti-beta-amyloid monoclonal antibody 266; Biotinylated m266 antibody - Eli Lilly; m266; m266 Fab; m266B antibody - Eli Lilly

Latest Information Update: 24 Jul 2006

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Washington University School of Medicine
  • Developer Eli Lilly
  • Class Monoclonal antibodies
  • Mechanism of Action Amyloid beta-protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Alzheimer's disease

Most Recent Events

  • 24 Jul 2006 Data presented at the 10th International Conference on Alzheimer's Disease and Related Disorders (ICAD-2006) have been added to the pharmacokinetics and Alzheimer's Disease and Cognition Disorders pharmacodynamics sections
  • 21 Jul 2006 Discontinued - Preclinical for Alzheimer's disease in USA (Injection)
  • 21 Sep 2001 Preclinical development for Alzheimer's disease in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top